The Discounted Cash Flow (DCF) valuation of Arcturus Therapeutics Holdings Inc (ARCT) is (61.59) USD. With the latest stock price at 6.50 USD, the upside of Arcturus Therapeutics Holdings Inc based on DCF is -1047.6%.
Based on the latest price of 6.50 USD and our DCF valuation, Arcturus Therapeutics Holdings Inc (ARCT) is a sell. selling ARCT stocks now will result in a potential gain of 1047.6%.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| WACC / Discount Rate | 5.7% - 8.0% | 6.9% |
| Long-term Growth Rate | 3.0% - 5.0% | 4.0% |
| Fair Price | (261.28) - (33.82) | (61.59) |
| Upside | -4119.6% - -620.3% | -1047.6% |